Omada Health is trading 5.6% down at $17.63, with no clear company-specific announcement explaining the October 16 move. - The investor news page lists November 5 for the next results announcement, not a new catalyst for October 16. - Broader pressure from hotter inflation, interest-rate concerns, and renewed selling in technology and AI-related stocks may be contributing to weakness. - Available reporting does not specifically attribute Omada Health’s move to that market backdrop.